Rather than engineer ever more toxic drugs to kill glioblastoma cells deep in the brain, Ravi Bellamkonda – based at Emory University School of Medicine and Georgia Institute of Technology, both in Atlanta – and his team wondered if they could move the tumours to a more accessible location.